Childhood cancer patients/survivors can apply to receive one of three (3) scholarships toward their college education. Recipients of the Sofia Blanco College Scholarships will receive a $2,000 allowance fortuition/room and board, plus a laptop or tablet (first-time awardees only).
Scholarship Details
- Three scholarships are available annually, each valued at $2,000
- First-time awardees also receive a laptop or tablet
- Award funds are paid directly to the recipient’s accredited college or university
- Recipients are eligible to reapply annually with additional requirements
Eligibility Criteria
- Must be a childhood cancer survivor or currently diagnosed with childhood cancer
- Must be enrolled in or accepted to an accredited undergraduate or graduate program in the U.S.
- Must provide a copy of an acceptance letter or letter of good standing from the college/university
- Must submit a completed Scholarship Application
- Must include at least one letter of recommendation from an academic teacher (maximum of three letters allowed, on official school letterhead)
- Must provide a letter from the attending physician verifying medical history and current medical status (confidential)
- Must submit a 500-word essay
Application Process
- Complete the Scholarship Application
- Prepare and submit the required documents, including:
- Acceptance letter or letter of good standing from the college/university
- At least one letter of recommendation (on official school letterhead)
- Letter from an attending physician (on official letterhead)
- Must agree to have their name, photo, and success story published by Sofia’s Hope
- 500-word essay
- Submit the completed application and supporting documents by March 15, 2025
- Await notification of scholarship decisions for the Fall Semester
Sofia's Hope was inspired by the life and death of Sofia Blanco at the age of thirteen after surviving Non-Hodgkin's lymphoma as a toddler. It is in her memory that Sofia's Hope fights cancer by: raising awareness of childhood cancer, specifically that while more children are surviving their diagnoses, 95% of them are facing a significant side effect by the time they are 45 years old; providing programs for patients and families currently in the journey; and funding research in the area of pediatric cardio-oncology which studies the effects of treatments on these children's hearts.